Jonathan Milner
InvestorInvestor at Cambridge Innovation Capital
Cambridge, Massachusetts
Writes $5K – $50K checks · typically $25K
About
Jonathan Milner earned a doctorate in Molecular Genetics at Leicester University after studying Applied Biology at Bath University, where he later worked as a post-doctoral researcher from 1992 to 1995. He subsequently researched the molecular basis of breast cancer at the University of Cambridge in Professor Tony Kouzarides' laboratory, and in 1998 co-founded the antibody supplier Abcam with David Cleevely and Professor Kouzarides. He has supported over 60 companies and helped bring three technology companies to IPO on AIM.
Invests in
Biotech
Experience
- Healx LtdChairmancurrent2025 — present
- NucleraChairmancurrent2024 — present
- Shift Bioscience LtdNon Executive Directorcurrent2017 — presentLetchworth, Herts
- The Milner Therapeutics InstituteCo Foundercurrent2016 — presentUniversity of Cambridge
- Sapperton WilderFoundercurrent2021 — presentSapperton, England, United Kingdom
- Natural History MuseumAmbassadorcurrent2013 — presentLondon Area, United Kingdom
- PhoreMost LtdNon Executive Directorcurrent2015 — presentGreater Cambridge Area
- LIfT BioSciencesInvestorcurrent2018 — presentLondon Area, United Kingdom
- SolasCureInvestorcurrent2018 — presentGreater Cardiff Area
- GelmetixInvestorcurrent2017 — presentManchester, UK
- PSYOMICS LTDLead Investorcurrent2017 — presentGreater Cambridge Area
- BitBio LtdInvestorcurrent2017 — presentGreater Cambridge Area
- DefiniGENInvestor2016 — 2025Greater Cambridge Area
- DefiniGENInvestor2016 — 2023Cambridge, UK
- Eagle Genomics Ltd.Investor2013 — 2025Greater Cambridge Area
- bit.bioInterim Chief Executive Officer2025Cambridge, England, United Kingdom
- Axol Bioscience Ltd.NED2013 — 2025Babraham, United Kingdom
- CamallergyChairman2013 — 2025Greater Cambridge Area
- AbcamFounder1998 — 2023Greater Cambridge Area
- AbcamFounder and CEO1998 — 2014Cambridge, UK
- Kind ConsumerInvestor2018 — 2023London Area, United Kingdom
- RepositiveInvestor2016 — 2023Greater Cambridge Area
- GeoSpock Ltd.Investor2015 — 2023Greater Cambridge Area
- CamnutraInvestor2013 — 2023Greater Cambridge Area
- Syndicate Room LtdNon-Executive Director2015 — 2021Greater Cambridge Area
- Villiers Park Educational TrustMember, Villiers Park Educational Trust Development Board2014 — 2018Foxton, United Kingdom
- Horizon DiscoveryFounder Investor2008 — 2018Greater Cambridge Area
- Frontier DevelopmentsInvestor2012 — 2017Greater Cambridge Area
- University of CambridgePost Doctoral Researcher1995 — 1998Department of Pathology
- University of BathPost Doctoral Researcher for Pfizer Pharmaceuticals1992 — 1995
Skills & more
Management1Leadership1Life Sciences15Biotechnology10Molecular Biology4Biochemistry4Immunology5Pharmaceutical Industry3Drug Discovery7Business Development4Technology Transfer3Start-ups9
+9 more
Cell CultureCommercializationScienceGeneticsGenomicsCell BiologyEntrepreneurshipR&DCellFrom Jonathan's professional profile.
Investments
Board seats
Axol BioscienceCamallergy LimitedElpis Biomedical LimitedHealX LimitedPhoreMost LimitedRepositive LimitedShift Biosciencs LimitedSyndicate Room Limited
Per the firm's website.
Colleagues at Cambridge Innovation Capital
Adam Glinsman
Investor at Cambridge Innovation Capital
Andrew Williamson
Managing Partner at Cambridge Innovation Capital
Andy Neely
Vice Chair at Cambridge Innovation Capital
Andy Richards
Investor at Cambridge Innovation Capital
Anne Horgan
Partner at Cambridge Innovation Capital
Christopher Tapper
Senior Associate at Cambridge Innovation Capital
Damian Crowther
Entrepreneur in Residence at Cambridge Innovation Capital
Dipesh Patel
Operating Partner at Cambridge Innovation Capital
Network2
Alastair KilgourScout
Founder at Parkwalk Advisors
)
Christine AylwardScout
Founder & Managing Partner at Magnetic Ventures
Investors connected to Jonathan in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Jonathan Milner?
- Jonathan Milner earned a doctorate in Molecular Genetics at Leicester University after studying Applied Biology at Bath University, where he later worked as a post-doctoral researcher from 1992 to 1995. He subsequently researched the molecular basis of breast cancer at the University of Cambridge in Professor Tony Kouzarides' laboratory, and in 1998 co-founded the antibody supplier Abcam with David Cleevely and Professor Kouzarides. He has supported over 60 companies and helped bring three technology companies to IPO on AIM.
- Where does Jonathan Milner work?
- Jonathan Milner is at Cambridge Innovation Capital.
- What does Jonathan Milner invest in?
- Jonathan Milner invests in Biotech.
- What check size does Jonathan Milner write?
- Jonathan Milner typically writes checks of $5K – $50K.
- What boards does Jonathan Milner sit on?
- Jonathan Milner holds tracked board seats at Axol Bioscience, Camallergy Limited, Elpis Biomedical Limited, HealX Limited, PhoreMost Limited, Repositive Limited, Shift Biosciencs Limited, Syndicate Room Limited.
- Where did Jonathan Milner go to school?
- Jonathan Milner studied at University of Bath (BA Hons in Applied Biology, Applied Biology); University of Leicester (Doctor of Philosophy (Ph.D.), Molecular Genetics); Anglia Ruskin University (Honorary).
Founder mafias
University of Bath mafia23
Also came through, then founded or led a company.
Iain DukesBScFounded Viriom +1Paul HetheringtonIntegrated Mechanical & Electrical Engineering (MEng)Founded Hlabs +1George Kalligeros(MEng) Masters in Mechanical EngineeringFounded Aseon +1Jes BroengPh.DFounded NorlaseCam KavanaghBSc EconomicsFounded GrowthkitchenSimon WillisonBScFounded Lanyrd
+ 16 more
University of Leicester mafia5
Also came through, then founded or led a company.
Anglia Ruskin University mafia3
Also came through, then founded or led a company.
Cambridge Innovation Capital mafia3
Also came through, then founded or led a company.
Same school
Also attended University of Bath110
Catherine BergersenSenior Executive Assistant at Mayfair Equity PartnersJohanInvestor at InvestinorMaddie CoughlinInvestor at DN CapitalCarlos ContiManaging Partner at Inveready Technology Investment GroupBen PalmerInvestment Professional at OxxJuliette PetitChief of Staff at Keen Venture Partners
+ 104 more
Also attended University of Leicester42
Drew BurdonInvestor at LSP (Life Sciences Partners)Nick CheethamGTM and Culture Expert at Notion CapitalDavid CassellsChief Financial Officer at GVP ClimateEd GregorySenior Legal Counsel at AirTree VenturesVasso FantousiLegal Counsel at RTP GlobalHuan NguyenOrigination - Private Equity at Rocket Capital
+ 36 more
Also attended Anglia Ruskin University8
Christian BuergerPortfolio Development at Intel CapitalMichaelFund Controller at Black SeedJakob LovenPartner at Nextech InvestFranco PontilloGeneral Partner at DOMO.VCSogiInvestor at EHE CapitalHelena HausenDirector Capital Formation & Sustainability at Beyond Capital Partners
+ 2 more
